Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Reba M. Knox"'
Autor:
Reba M. Knox, Otoniel Martinez-Maza, Angela Echeverri, Meta van der Meijden, Elizabeth C. Breen, Daniel P. Widney, Steven A. Miles, Larry Magpantay
Publikováno v:
Memórias do Instituto Oswaldo Cruz., Vol 93, Iss 3, Pp 373-381 (1998)
Memórias do Instituto Oswaldo Cruz, Volume: 93, Issue: 3, Pages: 373-381, Published: MAY 1998
Memórias do Instituto Oswaldo Cruz., Vol 93, Iss 3, p 373 (1998)
Memórias do Instituto Oswaldo Cruz, Volume: 93, Issue: 3, Pages: 373-381, Published: MAY 1998
Memórias do Instituto Oswaldo Cruz., Vol 93, Iss 3, p 373 (1998)
Much has been learned about how HIV-induced immune dysfunction contributes to B cell hyperactivation, and potentially, to the pathogenesis of AIDS-lymphoma. However, further studies are needed to fully understand how HIV infection and immune dysfunct
Autor:
F. J. Montz, Michael T. Johnson, Ahmad Rezai, William J. Ryan, Reba M. Knox, Christine H. Holschneider
Publikováno v:
Cancer Chemotherapy and Pharmacology. 34:166-170
The cytotoxicity and antitumor effects of the acetogenin Bullatacin were evaluated in vitro in multiple ovarian cancer cell lines and in vivo in a murine ovarian teratocarcinoma (MOT) model in C3HeB/FeJ mice. The in vitro cytotoxicity of Bullatacin a
Autor:
Reba M. Knox, Jonathan S. Berek, Klara Kaldi, Catherine Chung, Otoniel Martinez-Maza, Joanna M. Watson
Publikováno v:
American Journal of Obstetrics and Gynecology. 164:1038-1043
Interleukin-6 is a pleiotropic cytokine with a wide range of effects, including induction of B-cell and cytotoxic T-cell differentiation, and induction of acute phase reactant production by hepatocytes. Interleukin-6 also can act as an autocrine grow
Autor:
F. Tak-atsuki, Reba M. Knox, Joanna M. Watson, Jonathan S. Berek, J.L. Sensintaffar, Otoniel Martinez-Maza
Publikováno v:
Gynecologic Oncology. 36:296-297
Autor:
Jonathan S. Berek, Tak Ashikaga, S. Eisenkop, Neville F. Hacker, R. Gerald Pretorius, Leo D. Lagasse, Reba M. Knox
Publikováno v:
Gynecologic Oncology. 34:66-69
The pharmacokinetics of intraperitoneal (ip) cisplatin were investigated in a murine model. Groups of six animals were studied at initial cisplatin concentrations (Ci) of 50, 100, 200, and 400 μg/ml, and at injection volumes (V) of 0.5, 1, 2, and 4
Autor:
John L. Cantrell, Jonathan S. Berek, Jacob Zighelboim, Leo D. Lagasse, Alan Lichtenstein, Reba M. Knox, Neville F. Hacker
Publikováno v:
Gynecologic Oncology. 15:136
Autor:
Leo D. Lagasse, T. Jung, Reba M. Knox, Neville F. Hacker, E. Bonnem, Jonathan S. Berek, Alan Lichtenstein, T. Greene, Jacob Zighelboim
Publikováno v:
Gynecologic Oncology. 20:259